Centralized National Ethical Review of Clinical Trials in Croatia

April 2009
Croatian Medical Journal;Apr2009, Vol. 50 Issue 2, p111
Academic Journal
No abstract available.


Related Articles

  • Growing Pains: Central Review Board Project Still Developing. Randal, Judith // JNCI: Journal of the National Cancer Institute;5/7/2003, Vol. 95 Issue 9, p636 

    Focuses on the U.S. National Cancer Institute's pilot project for the central institutional review board (IRB), which aims to enable local IRB to retain their responsibility for the ethical quality of trial protocols but to spare them from the duplication of effort. Factors that pose problems...

  • Clinical trials: two neglected ethical issues. Herxheimer, Andrew // Journal of Medical Ethics;Dec93, Vol. 19 Issue 4, p211 

    Studies the ethical reasons behind clinical trials. Systematic reviews, publications, and registration of clinical trials; Implications.

  • Developing National Systems for Ethical Review in Eastern Europe and Central Asia. Kundiiev, Yurii I.; Vitte, Peter N.; Chashchin, Nicolay; Mishatkina, Tatyana; Sarymsakova, Bakhyt // Pharmaceutical Medicine - New Zealand;2008, Vol. 22 Issue 5, p285 

    This article discusses the developing of national systems for ethical review and the possibility of harmonizing Good Clinical Practice (GCP) ethical principles and guidelines in Eastern Europe and Central Asia countries and across the region as a whole.

  • Research ethics committees: Need for harmonization at the national level, the global and Indian perspective. Aparna Sanjiv Walanj // Perspectives in Clinical Research;Apr-Jun2014, Vol. 5 Issue 2, p66 

    Ethics committee (EC) organization and standardization is an important aspect of clinical research. There is a healthy trend worldwide to register and/or accredit research ECs reviewing clinical research. This article tries to focus on the existing model of ECs worldwide, as against the Indian...

  • WHO and industry combine to form ethics body. Dickson, David // Nature Medicine;Jul2002, Vol. 8 Issue 7, p645 

    Reports that the World Health Organization (WHO) is joining forces with the pharmaceutical industry to create a new body that will provide ethical review of clinical trials. Plans for providing some form of central coordination for ethical review committees in developing countries; Role played...

  • Discover Russia. Varshavsky, Sergei // Applied Clinical Trials;Mar2002, Vol. 11 Issue 3, p74 

    Reports the policy on clinical trials in Russia. Creation of good clinical practice rules to support drug companies; Responsibility of the National Ethics Committee in the monitoring of the ethical expertise; Implications of Federal Drug Law for clinical trials.

  • Using Central IRBs for Multicenter Clinical Trials in the United States Flynn, Kathryn E.; Hahn, Cynthia L.; Kramer, Judith M.; Check, Devon K.; Dombeck, Carrie B.; Bang, Soo; Perlmutter, Jane; Khin-Maung-Gyi, Felix A.; Weinfurt, Kevin P. // PLoS Clinical Trials;Jan2013, Vol. 8 Issue 1, p1 

    Research institutions differ in their willingness to defer to a single, central institutional review board (IRB) for multicenter clinical trials, despite statements from the FDA, OHRP, and NIH in support of using central IRBs to improve the efficiency of conducting trials. The Clinical Trials...

  • Sponsor-investigator-relationship: challenges, recent regulatory developments and future legislative trends. Ciuman, Raphael Richard // Health (1949-4998);Dec2011, Vol. 3 Issue 12, p772 

    Correct definition and management of sponsorinvestigator relationship is of central importance for planing and executing clinical trials. During the last decade, there have been numerous modifications of guidelindes, international and national legislations and regulations. This implicated...

  • A Central Institutional Review Board for Multi-Institutional Trials. Christian, Michaele C.; Goldberg, Jacquelyn L.; Killen, Jack; Abrams, Jeffrey S.; McCabe, Mary S.; Mauer, Joan K.; Wittes, Robert E. // New England Journal of Medicine;5/2/2002, Vol. 346 Issue 18, p1405 

    Discusses the effectiveness of institutional review boards (IRB), which is believed to have been undermined. Origins of the central review board; Protection of patients taking part in clinical trials; Challenge to define and adjudicate overlapping responsibilities within the system; Protocols...

  • Ethics of clinical trials in Nigeria. Okonta, Patrick I. // Nigerian Medical Journal;May/Jun2014, Vol. 55 Issue 3, p188 

    The conduct of clinical trials for the development and licensing of drugs is a very important aspect of healthcare. Drug research, development and promotion have grown to a multi-billion dollar global business. Like all areas of human endeavour involving generation and control of huge financial...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics